ATRCAtriCure, Inc.
$55.80+53% 1Y
$55.80
$25.8652 weeks$60.73
The financials
AtriCure, Inc. by the numbers
AtriCure, Inc. (ATRC) reported revenue of $154M in Q2 2026 (quarter ended Jun 30, 2026), up 13% from the same quarter a year earlier. That came with a gross margin of 77% and net income of $9.0M (5.8% of revenue). For the full year FY2025, revenue was $535M (+15% year on year) and net income −$11M. Its largest region in Q2 2026 was United States at $41M, 51% of the disclosed total, well ahead of Europe at 21%. The next results filing is expected around Oct 28, 2026, the same week as a year ago.
| Income statement | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Revenue | $154M | $136M | +13% |
| Gross profit | $119M | $101M | +17% |
| Operating income | $9.7M | −$6.2M | to a profit |
| Net income | $9.0M | −$6.2M | to a profit |
| Diluted EPS | $0.18 | −$0.13 | to a profit |
| Geographic | Revenue | Share |
|---|---|---|
| United States | $41M | 51% |
| Europe | $17M | 21% |
| Non Us | $11M | 14% |
| Asia Pacific | $8.6M | 11% |
| Other International | $2.2M | 2.7% |
Business segments
Revenue split by geographic segment, from SEC XBRL filings.
Latest period: Jun 2026Total $80.1M (+8.8%)
Asia Pacific grew +15% year on yearEurope +6.7% year on year
Segment Latestquarter on quarteryear on year
- United States$40.9M$40.9Mquarter on quarter +4.6%year on year +12%+4.6%+12%
- Europe$17.2M$17.2Mquarter on quarter +7.1%year on year +6.7%+7.1%+6.7%
- Non Us$11.2M$11.2Mquarter on quarter +18%year on year +8.6%+18%+8.6%
- Asia Pacific$8.6M$8.6Mquarter on quarter +22%year on year +15%+22%+15%
- Other International$2.2M$2.2Mquarter on quarter +15%year on year +12%+15%+12%
Medical Instruments & Supplies
Ranks #17 of 21 by RyuScore